Alzheimer’s Research progress provides ‘reasons to be hopeful

It seems there is more focus on Alzheimer’s research than ever before, and a great deal of progress has been made as a result.
The last 20 years alone have seen the discovery of the role beta-amyloid and tau proteins play in Alzheimer’s, FDA approval of the first Alzheimer’s drug for memory and thinking symptoms, the first Alzheimer’s mouse model and the first potential blood test for Alzheimer’s.

As a result of Alzheimer’s research, there are an array of drugs in development that scientists believe have great potential to effectively treat the disease.

“Many researchers believe successful treatment will eventually involve a ‘cocktail’ of medications aimed at several targets, similar to current state-of-the-art treatments for many cancers and AIDS,” says Snyder.

Talking to Medical News Today, Dr. Laurie Ryan, of the Division of Neuroscience at the NIA, said that there are “reasons to be hopeful” when it comes to finding effective treatments for Alzheimer’s.

“Advances in imaging now allow us to ‘see’ Alzheimer’s pathology in the living brain, and over the past few years, genome-wide association studies have identified gene variants that appear to play a role in the disease and may be targeted for interventions,” she noted. “We are testing a number of potentially promising interventions, from exercise, to hormones, to newly funded prevention trials.”

Courtesy: Medical News Today, United States